fashion -WSS

fashion

author：fashion 2025-09-30 09:31:08 - browse：7693

Adobe

The Food and Drug Administration has cleared Otsuka Pharmaceutical’s digital treatment for major depressive disorder, offering a new option for millions of people who struggle with the stubborn mental health condition.

Called Rejoyn, the smartphone-based treatment for major depressive disorder symptoms was developed with digital health company Click Therapeutics, and it is intended for use by prescription alongside antidepressants. The six-week program delivers a novel “cognitive-emotional training” technique, in which people are asked to identify and recall faces showing different emotions. Researchers hypothesize that the technique targets the brain’s dorsolateral prefrontal cortex and the amygdala and may “enhance cognitive control over emotional information processing.” Patients also receive cognitive behavioral therapy.

Rejoyn has been in development since 2018, and Otsuka is the first drug company to receive FDA clearance for a digital treatment for a mental health condition. But that landmark comes amid many questions about whether such digital therapeutics deliver their advertised results — and whether they can gain traction with clinicians, insurers, and patients. Prescription digital therapeutics have yet to see a blockbuster success, and several companies have gone out of business trying to create one.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： UnitedHealth argues against case alleging wrongful AI care denials

entertainment

hotspot

WSS

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

'Investigate these claims': UFO transparency at center of House hearing

What causes rare myocarditis in young men after Covid vaccines?

Investigation reveals sickle cell patients pressured into sterilizations

What causes rare myocarditis in young men after Covid vaccines?

The haunting brain science of long Covid

focus

fashion

hotspot

United colonoscopy coverage change 'may cost lives,' doctors say

What it's like to live with paralysis for one psychologist

FDA approval of Sarepta Duchenne genetic therapy gives me hope

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

Duchenne breakthrough therapy leaves behind pioneering families

Senate panel puts off hardest PBM reforms for another day

Medical leaders decry Supreme Court decision on affirmative action

UHS says company favors patients whose insurance pays more

DIEP, the 'gold standard' of breast reconstruction, is under threat

Former reverend arrested for allegedly killing 8

Wikipedia

Eyeing GLP

Former reverend arrested for allegedly killing 8

New lawsuit accuses health insurer Cigna of denying claims in bulk

Bird flu surveillance in wastewater gets boost from consortium

The haunting brain science of long Covid

CDC Director Mandy Cohen on transparency, trust, and health

entertainment

hotspot

focus

entertainment